Showing results out of
Supported by EMBL services, students Misha Hegde & Mia Maurer have identified a previously unknown bacteriophage that targets Rhizobium rhizogenes, a pathogen harming crops. Using cutting-edge imaging and DNA sequencing at EMBL Heidelberg, they are exploring its potential as a natural alternative…
SCIENCE & TECHNOLOGY2025
science-technology
EMBL and its partners have received funding from the European Commission for two new Twinning Projects, which will build expertise and research capacity in its member states.
CONNECTIONS2024
connections
During a visit from high-level representatives of EMBL’s member state Malta, the honourable delegation allowed a peek behind the scenes of their scientific and institutional collaborations, and shared their memories and future aspirations for the partnership.
CONNECTIONS2024
connectionsevents
A new collaborative study led by EMBL group leaders Kiran Patil, Nassos Typas, and Peer Bork has found that common medications accumulate in human gut bacteria. This process reduces drug effectiveness and affects the metabolism of common gut microbes, thereby altering the gut microbiome.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Scientists at EMBL Heidelberg are contributing their expertise in a community effort to develop large-scale testing methods for coronavirus. Their goal is to increase the capacity and speed of testing, which is crucial for containing the pandemic.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Three international teams involving EMBL Heidelberg have been granted funding from the European Commission for three Twinning projects with institutes in Portugal and the Czech Republic.
CONNECTIONSLAB MATTERS2020
connectionslab-matters
EMBL’s Genomics Core Facility supports students participating in the annual iGEM competition.
SCIENCE & TECHNOLOGY2019
sciencescience-technology
EMBL’s GeneCore steps up to discover the facts and settle disputes
LAB MATTERS2018
lab-matters
No results found